- $16.13m
- $9.90m
- $28.51m
Brief: Bionano Announces Appointment Of Gülsen Kama As CFO
Bionano Genomics Inc reports results for the quarter ended in June - Earnings Summary
Bionano Genomics Inc expected to post a loss of $1.03 a share - Earnings Preview
Brief: Bionano Genomics Announces Reverse Stock Split
Bionano Genomics Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Bionano Announces Stratys System For OGM And VIA Software For Hematologic Malignancies
Brief: Bionano Genomics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
U.S. RESEARCH ROUNDUP-Amyris, APi Group, Rambus
U.S. RESEARCH ROUNDUP-Axon Enterprise, RingCentral, Roblox
Bionano Genomics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Bionano Genomics Q1 revenue USD 7.4 million
Bionano Genomics Inc expected to post a loss of 8 cents a share - Earnings Preview
Bionano Genomics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Bionano Genomics Inc Says Preliminary Total Revenues For Q1 2023 Are Expected To Be In Range Of $7.3 Million To $7.5 Million
Brief: Bionano Genomics posts Outlook FY revenue of USD 35-38 million
Brief: Bionano Announces First Study Using Ogm To Discover Structural Variants With Potential Relevance To Genetic Diagnosis Of Mrkh Syndrome, A Syndrome Impacting Reproductive System Development In 1 In 4,500 Females
Brief: Bionano Labs Expands Clinical Testing Menu With Launch Of OGM-Based LDTs
Brief: Bionano Genomics As Of March 10 Has About $2.1 Mln In Accounts With SVB
Bionano Genomics Inc reports results for the quarter ended in December - Earnings Summary